Investment
Features
FeesSafety
Academy
More
Pluang+

June PCE inflation slows, easing some pressure on Fed rate hikes amid market jitters.

Market News
30 Jul 2026
Fox Business
View Source
Neutral
pluang ai news

The U.S. personal consumption expenditures (PCE) inflation index fell 0.1% in June and rose 3.7% year-over-year, matching economists' expectations. Core PCE, which excludes food and energy, increased 0.1% monthly and 3.3% annually, slightly cooler than predicted. This slowdown in inflation, especially the drop in headline PCE from 4.1% to 3.7%, may reduce pressure on the Federal Reserve to raise interest rates aggressively. Investors remain cautious as inflation fears, rising oil prices, and weak tech earnings continue to impact markets.

More News

Sanofi releases its half-year 2026 financial report and updates on business progress.

Sanofi releases its half-year 2026 financial report and updates on business progress.

Sanofi has published its financial report for the first half of 2026, available on its website and filed with the French financial authority (AMF). The biopharmaceutical company highlights its innovation in R&D and use of AI to drive long-term growth...

Company Fundamentals
Neutral
37 minutes ago
Financial advisors Frank Patton and Kimberlee Mott join Balmville Wealth Group via LPL Financial to expand client services.

Financial advisors Frank Patton and Kimberlee Mott join Balmville Wealth Group via LPL Financial to expand client services.

Frank Patton and Kimberlee Mott, financial advisors with 45 years of combined experience managing about $150 million in assets, have joined Balmville Wealth Group through LPL Financial. They bring a focus on retirement planning and multigenerational ...

Market News
Bullish
1 hour ago
Crescent Biopharma reports Q2 2026 results, advances cancer drug trials, and raises $143.7M to fund operations through 2028

Crescent Biopharma reports Q2 2026 results, advances cancer drug trials, and raises $143.7M to fund operations through 2028

Crescent Biopharma announced its second quarter 2026 financial results, highlighting progress in clinical trials for its cancer therapies, including CR-001, a PD-1 x VEGF bispecific antibody, and ADC candidates CR-002 and CR-003. The company is enrol...

Company Fundamentals
Bullish
2 hours ago
Ferrari raises 2026 guidance after Q2 revenue and profit rise on strong personalization demand

Ferrari raises 2026 guidance after Q2 revenue and profit rise on strong personalization demand

Ferrari reported Q2 2026 net revenues of €1.94 billion, up 8% year-on-year, driven by a richer product mix and increased personalization sales. Operating profit rose 10% to €605 million with a margin of 31.2%, while net profit grew 9% to €463 million...

Company Fundamentals
Bullish
3 hours ago
Primary Health Properties shows strong growth and a 7.5% dividend yield, boosted by Assura merger savings.

Primary Health Properties shows strong growth and a 7.5% dividend yield, boosted by Assura merger savings.

Primary Health Properties Plc continues to demonstrate solid organic rental growth and a robust 7.5% dividend yield, supported by accelerating rents and cost savings from its merger with Assura. The company reported a 9% rise in interim earnings per ...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App